Streetbeat News

Revenues

IOVA

Piper Sandler downgraded Iovance Biotherapeutics (NASDAQ: IOVA) due to slow uptake of its newly approved skin cancer cell therapy, Amtagvi. The price target was slashed by 40%, and revenue estimates for 2024 were significantly reduced.

Portfolio Pulse from Vandana Singh

July 29, 2024 | 5:55 pm

AMC

DIS

Disney shares are trading higher due to the strong box office performance of 'Deadpool & Wolverine,' which set IMAX records and achieved an all-time opening weekend record for an R-rated film. AMC Entertainment also benefited from the film's success, with it becoming their highest revenue-generating merchandise program of the year. Disney is set to report its third-quarter earnings on August 7th.

Portfolio Pulse from Vaishali Prayag

July 29, 2024 | 5:51 pm

AAPL

Bank of America analyst Wamsi Mohan reiterated a Buy rating for Apple Inc (NASDAQ:AAPL) with a price target of $256 ahead of its Q3 earnings report on August 1. Mohan predicts slightly higher-than-expected revenue and EPS, and highlights the importance of AI, Chinese market share, and services revenue. Apple’s new AI initiative, 'Apple Intelligence,' is expected to drive an upgrade cycle and boost revenue.

Portfolio Pulse from Hayden Buckfire

July 29, 2024 | 5:35 pm

EW

Edwards Lifesciences (NYSE:EW) has significantly outperformed the market over the past 20 years, delivering an average annual return of 16.83%. A $100 investment in EW 20 years ago would be worth $2,203.74 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 5:32 pm

AAPL

AMG

AMZN

ARLP

CNA

MCD

META

MSFT

ON

RVTY

SCHW

SPY

TLT

TSLA

XLE

XLY

Wall Street opened higher on Monday, driven by optimism ahead of major tech earnings and the Federal Reserve's meeting. Tesla rebounded 5% after a bullish note from Morgan Stanley, while oil prices dropped to 7-week lows. Key economic data and earnings reports from major companies like Microsoft, Apple, Meta, and Amazon are expected this week.

Portfolio Pulse from Piero Cingari

July 29, 2024 | 5:31 pm

AMD

MSFT

AMD is set to report its Q2 earnings, with analysts expecting revenue of $5.72 billion and EPS of 68 cents. Key factors include potential order cuts from Microsoft affecting MI300 revenue and guidance on the Data Center segment. Analysts have mixed views, with some warning of downside risks.

Portfolio Pulse from Chris Katje

July 29, 2024 | 5:20 pm

MU

QQQ

Micron Technology Inc (MU) shares have been volatile in July, influenced by potential US restrictions on China, geopolitical tensions, and mixed tech earnings. The semiconductor sector, including Micron, faces potential impacts from reduced AI and data center investments, economic uncertainties, and inventory pressures.

Portfolio Pulse from Henry Khederian

July 29, 2024 | 5:06 pm

TLRY

Tilray Brands Inc (NASDAQ:TLRY) announced that its subsidiary, Aphria RX GmbH, received a trading license in Germany, allowing it to sell and distribute medical cannabis products. This development is expected to strengthen Tilray's position in the German market and enhance its global leadership in cannabis research, cultivation, production, and distribution.

Portfolio Pulse from Adam Eckert

July 29, 2024 | 4:44 pm

PBI

Pitney Bowes is still working to conclude its strategic review of the company's global e-commerce segment. The company has sold the segment's fulfillment services business, which is a small part of the global e-commerce segment.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 4:40 pm

BTCUSD

ETHUSD

Bitcoin's potential to break past $70,000 is influenced by macroeconomic factors such as U.S. interest rate policies, inflation, and political support. Key events like the FOMC meeting on July 31 and the CPI report on August 14 will be critical. Bitcoin's market dominance has increased, partly due to a shift from Ethereum, and political support could further boost its price.

Portfolio Pulse from Khyathi Dalal

July 29, 2024 | 4:39 pm